New patent for Eisai Inc drug HALAVEN

   August 16, 2022    Comments Off on New patent for Eisai Inc drug HALAVEN    Posted in: Patent Added

Annual Drug Patent Expirations for HALAVEN Halaven is a drug marketed by Eisai Inc and is included in one NDA. It is available from two suppliers. There are two patents…

The post New patent for Eisai Inc drug HALAVEN appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog